跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
INTESTIFALK 4 MG SUPOSITORIOS
Approved
STANDARD
INTESTIFALK 4 MG SUPOSITORIOS
Dr. Falk Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 7, 2023
Approval ID
f12c17986f83ef2b
Company
Dr. Falk Pharma Gmbh
Type
Standard
Approval Details
Approval Id
f12c17986f83ef2b
Drug Cima Aemps Name
INTESTIFALK 4 MG SUPOSITORIOS
Register Number
88386
Holder Company Name
Dr. Falk Pharma Gmbh
Marketing Company Name
Dr. Falk Pharma Espana S.L.
Holder Company Detail Path
/organization/doktor-falk-farma-gmbkh-predstavitelstvo
Authorization Date
2023-03-07
Dosage Form
SUPOSITORIO
Dose
4 mg
Route Of Administration
VÍA RECTAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Dr. Falk Pharma Gmbh
Company Detail Path
/organization/doktor-falk-farma-gmbkh-predstavitelstvo
Company Information
Pharmaceutical Company Name
DOKTOR FALK FARMA GMBKH, PREDSTAVITELSTVO
Country Name
Russia
City Name
moscow,moscow,country_ru
Address
d. 68/70 str. 4, ul. Butyrski Val
Website
http://www.drfalkpharma.de
Active Ingredients
BUDESONIDA
4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 7, 2023
Approval ID
f12c17986f83ef2b
Type
Standard
Back to CIMA-AEMPS Approvals
INTESTIFALK 4 MG SUPOSITORIOS - CIMA-AEMPS Drug Approval Details